Vytalize Health Valuation Estimate
Vytalize Health Valuation as of Last Funding Round
Vytalize Health Company Overview
Vytalize Health designed a new care delivery system tailored to Medicare patients. Their care delivery model aims to transform the experience of over 260,000 Medicare beneficiaries across 36 states in the US. Their value-based platform has data analytics about patients, practice, enrollment, and finances. In 2021, they garnered $100 million in funding in a round led by Monroe Capital and Enhanced Healthcare Partners, with participation from North Coast Ventures.
Vytalize Health Valuation History
Vytalize Health Stock Price
The stock price of Vytalize Health can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Vytalize Health has issued 250 million shares, at the estimated UpMarket valuation of $113.48 million, each share of Vytalize Health stock would be worth $0.45.
Buy Vytalize Health Stock
If you would like to buy shares in Vytalize Health, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Vytalize Health stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Vytalize Health as well.
Vytalize Health Management
| Name | Position |
|---|---|
| Faris Ghawi | CEO |
